Full Text Journal Articles by
Author Ivan Kralj

Advertisement

Find full text journal articles








Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.

Ivan Kralj, Irene Boos, Uwe Müller-Bühl,

<h4>Background</h4>Advances in stent technology have widened the field of indications for stent treatment of femoro-popliteal artery lesions, however the use of stents in bending arterial segments is restricted because some first- and second-generation nitinol stent designs did not respond well to the mechanical forces of femoro-popliteal segments in motion which ... Read more >>

Vasa (VASA. Zeitschrift fur Gefasskrankheiten)
[2013, 42(5):340-349]

Cited: 7 times

View full text PDF listing >>



MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.

Karl-Ludwig Schulte, Ivan Kralj, Hans Martin Gissler, Luis Alberto Bagnaschino, Ivo Buschmann, Jean-Marc Pernès, Patrick Haage, Peter Goverde, Jean-Paul Beregi, Martin Válka, Jaroslav Boudny, Thomas Geibel, Marek Velkoborsky, Markus Zähringer, Christian Paetzel, Fabrizio Fanelli, Stefan Müller-Hülsbeck, Thomas Zeller, Ralf Langhoff,

<h4>Purpose</h4>To evaluate the safety and efficacy of the Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial (ClinicalTrials.gov; identifier NCT01118117).<h4>Methods</h4>Between April and October 2008, the registry enrolled 744 patients (496 men; 69 ± 10 years) who had symptomatic ≥ 70% ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2012, 19(6):774-784]

Cited: 24 times

View full text PDF listing >>



Advertisement

Management of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment option.

Robert M Cannon, Jose Urbano, Ivan Kralj, Petar Bosnjakovic, Robert C G Martin,

<h4>Background</h4>Multinodular hepatocellular carcinoma (HCC; ≥ 10 lesions) has been considered a controversial indication for transarterial chemoembolization (TACE) based on the extent of disease and the belief that no clinical benefit can be achieved. The aim of this study was to assess the safety and efficacy of chemoembolization with doxorubicin-eluting beads ... Read more >>

Onkologie (Onkologie)
[2012, 35(4):184-188]

Cited: 1 time

View full text PDF listing >>



Hepatic arterial therapy as a bridge to ablation or transplant in the treatment of hepatocellular carcinoma.

Russell Ware Farmer, Ivan Kralj, Alessandr Valdata, Jose Urbano, Daniel P Enguix, Ricardo García Mónaco, C R Scoggins, K M McMasters, Lisa Rustein, Robert C G Martin,

Hepatocellular carcinoma (HCC) is a challenging malignancy as a result of the advanced course at presentation. Recent interventional advances have improved treatment of lesions unamenable to resection using drug-eluting microbeads delivered into the hepatic circulation. We hypothesize that the use of hepatic arterial therapy (HAT) will safely identify appropriate ... Read more >>

Am Surg (The American surgeon)
[2011, 77(7):868-873]

Cited: 1 time

View full text PDF listing >>



Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.

Suzanne C Schiffman, Tiffany Metzger, Gregory Dubel, Tomas Andrasina, Ivan Kralj, Cliff Tatum, Kelly M McMasters, Charles R Scoggins, Robert C G Martin,

<h4>Background</h4>Unresectable intrahepatic cholangiocellular carcinoma (ICC) carries a poor prognosis, and there are few chemotherapeutic treatments to prolong survival. The purpose of this study was to assess the efficacy of drug-eluting bead (DEB) therapy by transarterial infusion for unresectable ICC.<h4>Methods</h4>A prospective multicenter study of ICC patients who received hepatic arterial DEB ... Read more >>

Ann Surg Oncol (Annals of surgical oncology)
[2011, 18(2):431-438]

Cited: 19 times

View full text PDF listing >>





Advertisement

Disclaimer
0.5596 s